Home > > Global Artificial Cornea and Corneal Implant Market Report
The Artificial Cornea and Corneal Implant market was valued at $406.9 Million in 2022, and is projected to reach $801.3 Million by 2032 growing at a CAGR of 7.07% from 2023 to 2032.The artificial cornea and corneal implant market is driven by a number of factors, including the increasing prevalence of eye disorders such as keratoconus, corneal injury and disease, and the increasing aging population. Other factors that are contributing to the growth of this market include the increasing awareness about corneal transplantation, advances in technology, and the availability of government funding for research and development. Some of the top companies in the artificial cornea and corneal implant market include CorNeat Vision, Ocular Science, KeraLink International, CorneaGen, and Holoclar. CorNeat Vision is a leading developer of artificial cornea implants. The company's KPro (keratoprosthesis) implant is a biocompatible, synthetic cornea that is designed to replace damaged or diseased corneas. The implant is made from a transparent, biocompatible material that is resistant to infection and inflammation, and has been shown to be effective in improving vision in patients with corneal disorders. Ocular Science is another leading player in the artificial cornea and corneal implant market. The company's Ocular Surface Prosthesis (OSP) is a synthetic corneal implant that is designed to restore vision in patients with corneal disorders. The OSP is made from a biocompatible material that is resistant to infection and inflammation, and has been shown to be effective in improving vision in patients with corneal disorders. KeraLink International is a leading provider of corneal transplantation services. The company's KeraLink Corneal Transplant Center is a state-of-the-art facility that offers a range of corneal transplantation services, including penetrating keratoplasty (PK), endothelial keratoplasty (EK), and anterior lamellar keratoplasty (ALK). CorneaGen is a leading developer of corneal implants and other products for the treatment of corneal disorders. The company's products include the i-Ring, a synthetic ring that is designed to support and stabilize the cornea in patients with keratoconus, and the DMEK (Descemet's membrane endothelial keratoplasty) tissue, which is used in corneal transplantation procedures. Holoclar is a leading developer of artificial cornea implants. The company's Holoclar implant is a biocompatible, synthetic cornea that is designed to replace damaged or diseased corneas. The implant is made from a transparent, biocompatible material that is resistant to infection and inflammation, and has been shown to be effective in improving vision in patients with corneal disorders.